Advertisement

Index by author

October 01, 1989; Volume 251,Issue 1

A

  1. Abraham, M I

    1. Specific inhibition of rat renal Na+/phosphate cotransport by picolinamide.
      P I Campbell, H A al-Mahrouq, M I Abraham and S A Kempson
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 188-192;

  2. al-Mahrouq, H A

    1. Specific inhibition of rat renal Na+/phosphate cotransport by picolinamide.
      P I Campbell, H A al-Mahrouq, M I Abraham and S A Kempson
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 188-192;

  3. Anis, N A

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

B

  1. Bakker-Woudenberg, I A

    1. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
      I A Bakker-Woudenberg, A F Lokerse and F H Roerdink
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 321-327;

  2. Balwierczak, J L

    1. Effects of adenosine A2 receptor agonists on nucleoside transport.
      J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;

  3. Barge, J

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

  4. Barrow, J

    1. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
      P W Kalivas, P Duffy and J Barrow
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 378-387;

  5. Bedell, K S

    1. Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
      J G Gerber, K S Bedell and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 77-81;

  6. Begovic, M E

    1. Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
      K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;

  7. Berghoff, W

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

  8. Bergman, J

    1. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
      B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;
    2. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.
      R D Spealman, B K Madras and J Bergman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 142-149;
    3. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
      J Bergman, B K Madras, S E Johnson and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 150-155;

  9. Bevan, J A

    1. Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve.
      M A Oriowo, J A Bevan and R D Bevan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 16-20;

  10. Bevan, R D

    1. Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve.
      M A Oriowo, J A Bevan and R D Bevan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 16-20;

  11. Bhargava, H N

    1. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
      H N Bhargava, A Gulati and P Ramarao
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 21-26;

  12. Biaggioni, I

    1. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
      S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;

  13. Birkett, D J

    1. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
      B C Sallustio, Y J Purdie, D J Birkett and P J Meffin
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 288-294;

  14. Boutis, L

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  15. Branch, R A

    1. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
      S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;

  16. Brody, M J

    1. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
      R E Solomon, M J Brody and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 27-38;

  17. Burks, T F

    1. Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
      J E Shook, T F Burks, J W Wasley and J A Norman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 247-252;

C

  1. Campbell, B G

    1. 1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
      J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;

  2. Campbell, P I

    1. Specific inhibition of rat renal Na+/phosphate cotransport by picolinamide.
      P I Campbell, H A al-Mahrouq, M I Abraham and S A Kempson
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 188-192;

  3. Canfield, D R

    1. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
      B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;

  4. Carbon, C

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

  5. Chen, J

    1. Effects of adenosine A2 receptor agonists on nucleoside transport.
      J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;

  6. Chiodo, L A

    1. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
      L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;

  7. Christianopoulou, M

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  8. Christoffersen, C L

    1. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
      L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;

  9. Conder, M L

    1. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
      G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;

  10. Connell, M J

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  11. Corna, D

    1. Renal handling of aspirin in the rat.
      F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;

  12. Costard-Jäckle, A

    1. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
      A Costard-Jäckle and M R Franz
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 39-46;

  13. Coughenour, L L

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

  14. Courtland, G G

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

  15. Członkowski, A

    1. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
      M J Millan, A Członkowski, A Lipkowski and A Herz
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 342-350;

D

  1. Daniel, E E

    1. Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
      P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;

  2. De Léan, A

    1. Disposition and dynamics of atrial natriuretic factor in conscious rabbits.
      S Marleau, H Ong, A De Léan and P du Souich
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 328-333;

  3. Dewey, W L

    1. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
      S P Welch, A K Singha and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 1-8;

  4. DiBona, G F

    1. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
      D R Kapusta, S Y Jones and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 230-237;

  5. Downs, D A

    1. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
      T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;

  6. Dozi-Vassiliades, J

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  7. Dromer, F

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

  8. Duffy, P

    1. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
      P W Kalivas, P Duffy and J Barrow
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 378-387;

  9. du Souich, P

    1. Disposition and dynamics of atrial natriuretic factor in conscious rabbits.
      S Marleau, H Ong, A De Léan and P du Souich
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 328-333;

E

  1. Einspahr, F J

    1. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
      M F Piercey and F J Einspahr
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 267-271;

  2. Eldefrawi, A T

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

  3. Eldefrawi, M E

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

F

  1. Fahey, M A

    1. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
      B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;

  2. Feletou, M

    1. Ammonium ions cause relaxation of isolated canine arteries.
      M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;

  3. Ferguson, E W

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  4. Franz, M R

    1. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
      A Costard-Jäckle and M R Franz
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 39-46;

  5. Freeman, A S

    1. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
      L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;

  6. Fujiwara, M

    1. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
      K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;

G

  1. Galligan, J J

    1. 1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
      J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;

  2. Ganapathy, V

    1. Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
      V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;

  3. Gant, D B

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

  4. Garattini, S

    1. Renal handling of aspirin in the rat.
      F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;

  5. Gaspari, F

    1. Renal handling of aspirin in the rat.
      F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;

  6. Gebhart, G F

    1. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
      R E Solomon, M J Brody and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 27-38;

  7. Gerber, J G

    1. Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
      J G Gerber, K S Bedell and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 77-81;

  8. Ghai, G R

    1. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
      A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;

  9. Goldberg, L I

    1. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
      Y Satoh, J D Kohli and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 253-257;

  10. Gordon, R J

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  11. Greischel, A

    1. Pharmacokinetics of recombinant human tumor necrosis factor alpha in rhesus monkeys after intravenous administration.
      A Greischel and G Zahn
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 358-361;

  12. Grover, G J

    1. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
      G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;

  13. Gulati, A

    1. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
      H N Bhargava, A Gulati and P Ramarao
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 21-26;

H

  1. Hanano, M

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

  2. Harker, C T

    1. Ammonium ions cause relaxation of isolated canine arteries.
      M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;

  3. Harris, A L

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  4. Heffner, T G

    1. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
      T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;
    2. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
      L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;

  5. Heikkila, R E

    1. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
      S Ofori, R E Heikkila and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 258-266;

  6. Henry, D E

    1. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
      G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;

  7. Herz, A

    1. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
      M J Millan, A Członkowski, A Lipkowski and A Herz
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 342-350;

  8. Hirai, K

    1. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
      T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;

  9. Hoover, R K

    1. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
      R K Hoover and M L Toews
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 63-70;

  10. Hutchison, A J

    1. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
      A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;

I

  1. Iga, T

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

  2. Ishizuka, H

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

  3. Ito, K

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

J

  1. Jackson, E K

    1. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
      S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;

  2. Jaffe, B M

    1. The role of serotonin in the canine secretory response to cholera toxin in vivo.
      C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;

  3. Jeng, A Y

    1. Effects of adenosine A2 receptor agonists on nucleoside transport.
      J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;

  4. Johnson, S E

    1. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
      J Bergman, B K Madras, S E Johnson and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 150-155;

  5. Joly, V

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

  6. Jones, S Y

    1. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
      D R Kapusta, S Y Jones and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 230-237;

K

  1. Kachel, D L

    1. Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
      W J Martin, D L Kachel, T Vilen and V Natarajan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 272-278;

  2. Kalivas, P W

    1. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
      P W Kalivas, P Duffy and J Barrow
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 378-387;

  3. Kang, Y S

    1. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
      T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;

  4. Kapusta, D R

    1. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
      D R Kapusta, S Y Jones and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 230-237;

  5. Kavanaugh, M P

    1. 1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
      J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;

  6. Kempson, S A

    1. Specific inhibition of rat renal Na+/phosphate cotransport by picolinamide.
      P I Campbell, H A al-Mahrouq, M I Abraham and S A Kempson
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 188-192;

  7. Kimura, K

    1. The role of serotonin in the canine secretory response to cholera toxin in vivo.
      C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;

  8. King, C H

    1. Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
      K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;

  9. Klein, M

    1. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents.
      M Klein and J M Musacchio
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 207-215;

  10. Kohli, J D

    1. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
      Y Satoh, J D Kohli and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 253-257;

  11. Komori, K

    1. Ammonium ions cause relaxation of isolated canine arteries.
      M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;

  12. Konno, K

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

  13. Kostka, P

    1. Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
      P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;

  14. Krulan, C M

    1. Effects of adenosine A2 receptor agonists on nucleoside transport.
      J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;

  15. Kulanthaivel, P

    1. Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
      V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;

  16. Kurahashi, K

    1. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
      K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;

  17. Kwan, C Y

    1. Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
      P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;

L

  1. Lai, J

    1. The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
      L Mei, J Lai, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 90-97;

  2. LaRosa, C A

    1. The role of serotonin in the canine secretory response to cholera toxin in vivo.
      C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;

  3. Lee, J C

    1. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
      H Y Meltzer, S Matsubara and J C Lee
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 238-246;

  4. Leibach, F H

    1. Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
      V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;

  5. Lialiaris, T

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  6. Lipkowski, A

    1. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
      M J Millan, A Członkowski, A Lipkowski and A Herz
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 342-350;

  7. Liu, P S

    1. Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
      K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;

  8. Locatelli, M

    1. Renal handling of aspirin in the rat.
      F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;

  9. Lokerse, A F

    1. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
      I A Bakker-Woudenberg, A F Lokerse and F H Roerdink
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 321-327;

  10. Lorens, S A

    1. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity.
      J M Paris and S A Lorens
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 388-393;

  11. Lukas, R J

    1. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
      R J Lukas
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 175-182;

M

  1. Madras, B K

    1. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
      B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;
    2. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.
      R D Spealman, B K Madras and J Bergman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 142-149;
    3. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
      J Bergman, B K Madras, S E Johnson and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 150-155;

  2. Mahesh, V B

    1. Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
      V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;

  3. Manabe, K

    1. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
      K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;

  4. Marleau, S

    1. Disposition and dynamics of atrial natriuretic factor in conscious rabbits.
      S Marleau, H Ong, A De Léan and P du Souich
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 328-333;

  5. Martin, W J

    1. Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
      W J Martin, D L Kachel, T Vilen and V Natarajan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 272-278;

  6. Matsubara, S

    1. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
      H Y Meltzer, S Matsubara and J C Lee
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 238-246;

  7. McCullough, J R

    1. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
      G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;

  8. McMahon, K K

    1. Developmental changes of the G proteins-muscarinic cholinergic receptor interactions in rat heart.
      K K McMahon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 372-377;

  9. Meffin, P J

    1. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
      B C Sallustio, Y J Purdie, D J Birkett and P J Meffin
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 288-294;

  10. Mei, L

    1. The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
      L Mei, J Lai, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 90-97;

  11. Meltzer, H Y

    1. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
      H Y Meltzer, S Matsubara and J C Lee
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 238-246;

  12. Meltzer, L T

    1. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
      T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;
    2. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
      L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;

  13. Mhatre, M

    1. Chronic ethanol treatment selectively increases the binding of inverse agonists for benzodiazepine binding sites in cultured spinal cord neurons.
      M Mhatre and M K Ticku
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 164-168;

  14. Miledi, R

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

  15. Millan, M J

    1. Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli.
      M J Millan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 334-341;
    2. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
      M J Millan, A Członkowski, A Lipkowski and A Herz
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 342-350;

  16. Mitchell, D Y

    1. Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase.
      D Y Mitchell and D R Petersen
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 193-198;

  17. Molas, G

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

  18. Money, S R

    1. The role of serotonin in the canine secretory response to cholera toxin in vivo.
      C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;

  19. Mourelatos, D

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  20. Musacchio, J M

    1. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents.
      M Klein and J M Musacchio
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 207-215;

  21. Myers, S L

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

N

  1. Natarajan, V

    1. Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
      W J Martin, D L Kachel, T Vilen and V Natarajan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 272-278;

  2. Nicklas, W J

    1. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
      S Ofori, R E Heikkila and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 258-266;

  3. Nies, A S

    1. Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
      J G Gerber, K S Bedell and A S Nies
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 77-81;

  4. Niles, L P

    1. Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
      P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;

  5. Norman, J A

    1. Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
      J E Shook, T F Burks, J W Wasley and J A Norman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 247-252;

  6. North, R A

    1. 1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
      J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;

O

  1. Oei, H H

    1. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
      A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;

  2. Ofori, S

    1. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
      S Ofori, R E Heikkila and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 258-266;

  3. Ong, H

    1. Disposition and dynamics of atrial natriuretic factor in conscious rabbits.
      S Marleau, H Ong, A De Léan and P du Souich
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 328-333;

  4. Oriowo, M A

    1. Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve.
      M A Oriowo, J A Bevan and R D Bevan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 16-20;

P

  1. Pagani, E D

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  2. Pan, Z Z

    1. Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro.
      Z Z Pan and J T Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 56-62;

  3. Papageorgiou, A

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  4. Papageorgiou, V

    1. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
      T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;

  5. Paris, J M

    1. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity.
      J M Paris and S A Lorens
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 388-393;

  6. Paul, S

    1. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
      S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;

  7. Perico, N

    1. Renal handling of aspirin in the rat.
      F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;

  8. Petersen, D R

    1. Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase.
      D Y Mitchell and D R Petersen
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 193-198;

  9. Piercey, M F

    1. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
      M F Piercey and F J Einspahr
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 267-271;

  10. Pimpl, W

    1. The role of serotonin in the canine secretory response to cholera toxin in vivo.
      C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;

  11. Pugsley, T A

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

  12. Purdie, Y J

    1. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
      B C Sallustio, Y J Purdie, D J Birkett and P J Meffin
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 288-294;

R

  1. Ragsdale, D

    1. Inhibition of rat brain glutamate receptors by philanthotoxin.
      D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;

  2. Ramarao, P

    1. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
      H N Bhargava, A Gulati and P Ramarao
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 21-26;

  3. Remuzzi, G

    1. Renal handling of aspirin in the rat.
      F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;

  4. Rhinehart, B L

    1. Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
      K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;

  5. Robertson, D

    1. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
      S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;

  6. Robinson, K M

    1. Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
      K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;

  7. Roerdink, F H

    1. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
      I A Bakker-Woudenberg, A F Lokerse and F H Roerdink
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 321-327;

  8. Roeske, W R

    1. The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
      L Mei, J Lai, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 90-97;

S

  1. Sallustio, B C

    1. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
      B C Sallustio, Y J Purdie, D J Birkett and P J Meffin
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 288-294;

  2. Sato, H

    1. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
      T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;

  3. Satoh, Y

    1. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
      Y Satoh, J D Kohli and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 253-257;

  4. Sawada, Y

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

  5. Seta, N

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

  6. Shepherd, J T

    1. Ammonium ions cause relaxation of isolated canine arteries.
      M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;

  7. Sherlock, D

    1. The role of serotonin in the canine secretory response to cholera toxin in vivo.
      C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;

  8. Shih, Y H

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

  9. Shirahase, H

    1. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
      K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;

  10. Shook, J E

    1. Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
      J E Shook, T F Burks, J W Wasley and J A Norman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 247-252;

  11. Silver, P J

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  12. Singha, A K

    1. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
      S P Welch, A K Singha and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 1-8;

  13. Sipos, S N

    1. Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
      P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;

  14. Sleph, P G

    1. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
      G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;

  15. Solomon, R E

    1. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
      R E Solomon, M J Brody and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 27-38;

  16. Spealman, R D

    1. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
      B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;
    2. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.
      R D Spealman, B K Madras and J Bergman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 142-149;
    3. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
      J Bergman, B K Madras, S E Johnson and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 150-155;

  17. Stevens, C W

    1. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
      C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 216-223;

  18. Stewart, S F

    1. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
      T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;

  19. Sugiyama, Y

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

  20. Suzuki, H

    1. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
      H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;

T

  1. Terasaki, T

    1. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
      T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;

  2. Ticku, M K

    1. Chronic ethanol treatment selectively increases the binding of inverse agonists for benzodiazepine binding sites in cultured spinal cord neurons.
      M Mhatre and M K Ticku
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 164-168;

  3. Tiruppathi, C

    1. Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
      V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;

  4. Toews, M L

    1. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
      R K Hoover and M L Toews
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 63-70;

  5. Tsuji, A

    1. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
      T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;

U

  1. Usui, H

    1. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
      K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;

V

  1. Vanhoutte, P M

    1. Ammonium ions cause relaxation of isolated canine arteries.
      M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;

  2. Vilen, T

    1. Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
      W J Martin, D L Kachel, T Vilen and V Natarajan
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 272-278;

W

  1. Wallace, A M

    1. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
      A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;

  2. Wang, Z C

    1. Effects of adenosine A2 receptor agonists on nucleoside transport.
      J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;

  3. Wasley, J W

    1. Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
      J E Shook, T F Burks, J W Wasley and J A Norman
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 247-252;

  4. Webb, R L

    1. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
      A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;

  5. Weber, E

    1. 1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
      J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;

  6. Welch, S P

    1. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
      S P Welch, A K Singha and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 1-8;

  7. Wiley, J N

    1. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
      T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;

  8. Williams, A E

    1. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
      T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;

  9. Williams, J T

    1. Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro.
      Z Z Pan and J T Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 56-62;

  10. Williams, M

    1. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
      A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;

Y

  1. Yaksh, T L

    1. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
      C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 216-223;

  2. Yamamura, H I

    1. The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
      L Mei, J Lai, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 90-97;

  3. Yeni, P

    1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
      V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;

Z

  1. Zahn, G

    1. Pharmacokinetics of recombinant human tumor necrosis factor alpha in rhesus monkeys after intravenous administration.
      A Greischel and G Zahn
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 358-361;

  2. Zimmerman, M B

    1. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
      A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
      Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;
Back to top

In this issue

Advertisement